Inferra AI / Company / NEOG

Neogen Corp

NEOG · Health Care

Last earnings Oct 6, 2026

Key results

Revenuequarter

$225.3 million

revenue of $225.3 million representing growth of (0.1%) and Core Growth 1 of 4.3%

SEC original ↗Neogen Corp — Earnings release (8-K exhibit)EX-99Jul 30, 2026

revenue of $870.4 million with growth of (2.7%) and Core Growth 1 of 1.9% &#x2022

SEC original ↗Neogen Corp — Earnings release (8-K exhibit)EX-99Jul 30, 2026

revenue grew 7% sequentially due to resolution of the majority of supply challenges &#x2022

SEC original ↗Neogen Corp — Earnings release (8-K exhibit)EX-99Jul 30, 2026

Free cash flowquarter

$26.2 million

free cash flow of $26.2 million &#x2022

SEC original ↗Neogen Corp — Earnings release (8-K exhibit)EX-99Jul 30, 2026

• Food Safety segment revenue was $166.8 million in the fourth quarter, increasing 3.1% relative to the fourth quarter of fiscal year 2025.

SEC original ↗Neogen Corp — Earnings release (8-K exhibit)EX-99Jul 30, 2026

Core Food Safety revenuequarter

5.8%

Core Food Safety revenue growth increased 5.8% on a year-over-year basis, the highest rate since the period immediately following the acquisition of the 3M Food Safety business in FY23.

SEC original ↗Neogen Corp — Earnings release (8-K exhibit)EX-99Jul 30, 2026

• Animal Safety segment revenue was $58.5 million in the fourth quarter, representing growth of (8.2%) relative to the fourth quarter of fiscal year 2025.

SEC original ↗Neogen Corp — Earnings release (8-K exhibit)EX-99Jul 30, 2026

Core Animal Safety revenuequarter

0.5%

Core Animal Safety revenue increased 0.5% on a year-over-year basis.

SEC original ↗Neogen Corp — Earnings release (8-K exhibit)EX-99Jul 30, 2026

EPSquarter

$612.2 million

diluted share, compared to a net loss of $612.2 million, or $(2.82)

SEC original ↗Neogen Corp — Earnings release (8-K exhibit)EX-99Jul 30, 2026

AI analysis

Q4 FY2026 · reported Jul 30, 2026

Based on: Earnings release + parent 8-K + 10-Q — transcript not held

Revenue · Q4 FY2026
$225.3M
EX-99 · Jul 30, 2026
Free cash flow · Q4 FY2026
$26.2M
EX-99 · Jul 30, 2026
EPS · Q4 FY2026
$612.2M
EX-99 · Jul 30, 2026

Headline figures

MetricQ4 FY2026Prior qtrYear ago
Revenue$225.3 million——
Free cash flow$26.2 million——
Core Food Safety revenue5.8%——
Core Animal Safety revenue0.5%——
EPS$612.2 million——

EX-99 · Jul 30, 2026

Guidance · company-stated

Direction: raised

No guidance located in the held release

Stated figure7%

“7% • Company on track to manufacture saleable Petrifilm product and begin planned multi-quarter manufacturing transition in November 2026; first single kit unit (SKU) fully validated • Raising fiscal year 2027 financial guidance for revenue and Adjusted EBITDA 1 1 Non-GAAP financial measures; see explanations and reconciliations that follow LANSING, October 6, 2026 – Neogen Corporation (NASDAQ: NEOG), an innovative leader in food safety solutions, announced its financial results for the first quarter of fiscal year 2027.”

Next earningsNo verified date on fileNo date is estimated or imported

Cash flow & capex

Free cash flow$26.2M

Capital allocation

The Company plans to use the proceeds from the transaction primarily for debt reduction.

Net debt is a non-GAAP measure calculated as total debt (current and non-current) less cash and cash equivalents.

General educational research only — not investment advice.Every figure is as stated in the held documents; values marked “computed from stated figures” are arithmetic on those stated figures. Guidance shown is the company’s own stated guidance. No price targets, no recommendations, no consensus estimates.

Event summary

Neogen Corp — Earnings release (2026-07-30)

Based on: Earnings release + parent 8-K + 10-Q — transcript not held

Guidance & outlook

No guidance located in the held release

Capital allocation

The Company plans to use the proceeds from the transaction primarily for debt reduction.

SEC original ↗Neogen Corp — Earnings release (8-K exhibit)EX-99Jul 30, 2026

Net debt is a non-GAAP measure calculated as total debt (current and non-current) less cash and cash equivalents.

SEC original ↗Neogen Corp — Earnings release (8-K exhibit)EX-99Jul 30, 2026

Net debt-to-Adjusted EBITDA is a non-GAAP ratio that uses net debt as the numerator and Adjusted EBITDA as the denominator.

SEC original ↗Neogen Corp — Earnings release (8-K exhibit)EX-99Jul 30, 2026

The Company uses net debt-to-Adjusted EBITDA to evaluate its leverage position and the expected impact of debt repayment and deleveraging initiatives.

SEC original ↗Neogen Corp — Earnings release (8-K exhibit)EX-99Jul 30, 2026

The Company’s senior credit facility contains financial covenants that utilize leverage ratios calculated using measures substantially similar to Adjusted EBITDA.

SEC original ↗Neogen Corp — Earnings release (8-K exhibit)EX-99Jul 30, 2026

As of May 31, 2026, total debt was $793.7 million, cash and cash equivalents were $185.5 million, resulting in net debt of $608.2 million.

SEC original ↗Neogen Corp — Earnings release (8-K exhibit)EX-99Jul 30, 2026

Strategy & priorities

“We ended fiscal year 2026 with significant momentum and have a number of initiatives underway to further enhance our commercial efforts and the way we approach customers and our core markets.

SEC original ↗Neogen Corp — Earnings release (8-K exhibit)EX-99Jul 30, 2026

Our entire organization is focused on disciplined execution and sustaining the operational momentum that we have seen in the business throughout fiscal year 2026.

SEC original ↗Neogen Corp — Earnings release (8-K exhibit)EX-99Jul 30, 2026

Adjusted EBITDA margins benefited from the impact of the Company's first quarter cost saving initiatives and improvements in gross margins.

SEC original ↗Neogen Corp — Earnings release (8-K exhibit)EX-99Jul 30, 2026

• Neogen is supporting efforts to counter the New World Screwworm (NWS) expansion in the United States.

SEC original ↗Neogen Corp — Earnings release (8-K exhibit)EX-99Jul 30, 2026

• The Company is in the process of launching its new global go-to-market strategy and enterprise-wide solutions-based selling model.

SEC original ↗Neogen Corp — Earnings release (8-K exhibit)EX-99Jul 30, 2026

Risks & headwinds

On a sequential basis, Animal Safety revenue increased by over 7% as the Company resolved the majority of the supply related challenges, which had resulted in product shortages.

SEC original ↗Neogen Corp — Earnings release (8-K exhibit)EX-99Jul 30, 2026

These “forward-looking statements” are management’s present expectations of future events as of the date hereof and are subject to a number of known and unknown risks and uncertainties that could cause actual results, conditions, and events to differ materially and adversely from those anticipated.

SEC original ↗Neogen Corp — Earnings release (8-K exhibit)EX-99Jul 30, 2026

(9) Includes costs primarily associated with shareholder litigation and other legal expenses and product recall expenses.

SEC original ↗Neogen Corp — Earnings release (8-K exhibit)EX-99Jul 30, 2026

(4) Includes costs primarily associated with shareholder litigation and other legal expenses and product recall expenses.

SEC original ↗Neogen Corp — Earnings release (8-K exhibit)EX-99Jul 30, 2026

(8) Includes costs primarily associated with shareholder litigation and other legal expenses and product recall expenses.

SEC original ↗Neogen Corp — Earnings release (8-K exhibit)EX-99Jul 30, 2026

Legal Proceedings 26 Item 1A.

SEC original ↗Neogen Corp — 10-Q Quarterly report10-QOct 7, 2026

Competitors

Competitors & peers

Same GICS sector — classification peers, not declared competitors

Documents

Filings

30 documents

Earnings releases

6 documents

Presentations

0 documents

No presentations for Neogen Corp are held in this edition of the library.

Transcripts

0 documents

No transcripts for Neogen Corp are held in this edition of the library.

See also the earnings calendar for every tracked company’s next earnings date.